Lysosomal Protein Transmembrane 4 beta (LAPTM4B) Peptide
LAPTM4B
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
Catalog No. ABIN936176
Quick Overview for Lysosomal Protein Transmembrane 4 beta (LAPTM4B) Peptide (ABIN936176)
Target
LAPTM4B
(Lysosomal Protein Transmembrane 4 beta (LAPTM4B))
Origin
Mammalian
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Peptide Type
- Synthetic
-
Sequence
- YPNSIQEYIR QLPPNFPYRD DVMSVNPTCL VLIILLFISI ILTFKGYLIS
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of LAPTM4 B antibody,
Alternative Names: LAPTM4B control peptide, LAPTM4B antibody Blocking Peptide, Anti-LAPTM4B Blocking Peptide, Lysosomal Associated Protein Transmembrane 4 Beta Blocking Peptide, LAPTM4beta Blocking Peptide, LC27 Blocking Peptide, LAPTM4B, LAPTMB-4, LAPTMB 4, LAPTMB-4 Blocking Peptide, LAPTMB 4 Blocking Peptide
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- LAPTM4B (Lysosomal Protein Transmembrane 4 beta (LAPTM4B))
-
Background
- LAPTM4B is a multi-pass membrane protein. It belongs to the LAPTM4/LAPTM5 transporter family. LAPTM4b has active role in disease progression of malignant cells and is involved in cell proliferation and multidrug resistance. The genetic polymorphism of LAPTM4B is a potential risk factor for the development of colon cancer and gastric cancer. The research results also indicated that LAPTM4B may be a clinically useful prognostic indicator for ovarian carcinoma and may play a role in human hepatocellular carcinoma.
-
Molecular Weight
- 35 kDa
Target
-
You are here:
